person · Reporting owner
Ballintyn Rhonda Germany
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 14, 2021 | May 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 14, 2021 · Filed May 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,162 |
Ending reported balance
After 2021-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-05-14 · Grant · Acquired 1,060 · Balance 14,266 Row 2 · 2021-05-14 · Grant · Acquired 2,896 · Balance 17,162 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1,584 |
Reported balance
Holding disclosure · report date 2021-05-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,584 |
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aegion Corp
Report date May 17, 2021 · Filed May 19, 2021
Section 16 reporting ended · disclosed 2021-05-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-05-17 transaction · row 1
1 source rowRow 1 · 2021-05-17 · Disposition to issuer · Disposed 30,110 · Balance 0 F1: On May 17, 2021, Carter Acquisition, Inc., a Delaware corporation ("Merger Sub") and a wholly-owned subsidiary of Carter Intermediate, Inc., a Delaware corporation ("Parent"), merged with and into Aegion Corporation (the "Company"), with the Company continuing as the surviving corporation (the "Merger"), pursuant to the previously announced Agreement and Plan of Merger, dated February 16, 2021 and amended on March 13, 2021 and April 13, 2021 (the "Merger Agreement") among Parent, Merger Sub and the Company. F2: Pursuant to the Merger Agreement, at the effective time of the Merger: (a) each outstanding share of Common Stock (each, a "Share"), par value $0.01 per share, of the Company was cancelled and thereafter entitled the Reporting Person to receive $30 in cash without interest and less any applicable tax withholdings (the "Merger Consideration") and (b) each restricted stock unit and deferred stock unit (each a "Stock Unit") outstanding immediately prior to the consummation of the Merger became fully vested (to the extent unvested) and was canceled and converted into the right to receive, for each Share subject to such then-vested Stock Unit, the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 17, 2021, Carter Acquisition, Inc., a Delaware corporation ("Merger Sub") and a wholly-owned subsidiary of Carter Intermediate, Inc., a Delaware corporation ("Parent"), merged with and into Aegion Corporation (the "Company"), with the Company continuing as the surviving corporation (the "Merger"), pursuant to the previously announced Agreement and Plan of Merger, dated February 16, 2021 and amended on March 13, 2021 and April 13, 2021 (the "Merger Agreement") among Parent, Merger Sub and the Company.
F2: Pursuant to the Merger Agreement, at the effective time of the Merger: (a) each outstanding share of Common Stock (each, a "Share"), par value $0.01 per share, of the Company was cancelled and thereafter entitled the Reporting Person to receive $30 in cash without interest and less any applicable tax withholdings (the "Merger Consideration") and (b) each restricted stock unit and deferred stock unit (each a "Stock Unit") outstanding immediately prior to the consummation of the Merger became fully vested (to the extent unvested) and was canceled and converted into the right to receive, for each Share subject to such then-vested Stock Unit, the Merger Consideration.
Univar Solutions Inc.
Report date August 01, 2023 · Filed August 03, 2023
Section 16 reporting ended · disclosed 2023-08-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-08-01 transaction · row 1
1 source rowRow 1 · 2023-08-01 · Disposition to issuer · Disposed 11,894 · Balance 0 F1: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-08-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-01 · Disposition to issuer · Disposed 28,886 · Balance 0 F2: In accordance with the Merger Agreement, at the effective time, each deferred stock unit was cashed out based on the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration").
F2: In accordance with the Merger Agreement, at the effective time, each deferred stock unit was cashed out based on the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2023 Filed Aug 3, 2023 21:59 UTC | Univar Solutions Inc. UNVR · Entity 110826 | Disposition to issuerDeferred Stock Units · Derivative | 28,886 | $36.15 | $1,044,228.90 |
DisclosureSEC source: 0000899243-23-017762 · doc4.xml · derivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,886 shares Expires not disclosed F2 · derivative.exercise_price: In accordance with the Merger Agreement, at the effective time, each deferred stock unit was cashed out based on the Merger Consideration. F2 · derivative.exercise_date: In accordance with the Merger Agreement, at the effective time, each deferred stock unit was cashed out based on the Merger Consideration. F2 · derivative.expiration_date: In accordance with the Merger Agreement, at the effective time, each deferred stock unit was cashed out based on the Merger Consideration. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 21:59 UTC | Univar Solutions Inc. UNVR · Entity 110826 | Disposition to issuerCommon Stock | 11,894 | $36.15 | $429,968.10 |
DisclosureSEC source: 0000899243-23-017762 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). F1 · price: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). Read SEC document |
| May 05, 2022 Filed May 5, 2022 20:32 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 4,630 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016994 · doc4.xml · derivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,886 Underlying: Common Stock · 4,630 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of DSUs Under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of DSUs Under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| May 17, 2021 Filed May 19, 2021 18:28 UTC | Aegion Corp AEGN · Entity 139259 | Disposition to issuerCommon Stock | 30,110 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-21-000614 · ownership.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On May 17, 2021, Carter Acquisition, Inc., a Delaware corporation ("Merger Sub") and a wholly-owned subsidiary of Carter Intermediate, Inc., a Delaware corporation ("Parent"), merged with and into Aegion Corporation (the "Company"), with the Company continuing as the surviving corporation (the "Merger"), pursuant to the previously announced Agreement and Plan of Merger, dated February 16, 2021 and amended on March 13, 2021 and April 13, 2021 (the "Merger Agreement") among Parent, Merger Sub and the Company. F2 · kind: Pursuant to the Merger Agreement, at the effective time of the Merger: (a) each outstanding share of Common Stock (each, a "Share"), par value $0.01 per share, of the Company was cancelled and thereafter entitled the Reporting Person to receive $30 in cash without interest and less any applicable tax withholdings (the "Merger Consideration") and (b) each restricted stock unit and deferred stock unit (each a "Stock Unit") outstanding immediately prior to the consummation of the Merger became fully vested (to the extent unvested) and was canceled and converted into the right to receive, for each Share subject to such then-vested Stock Unit, the Merger Consideration. F1 · price: On May 17, 2021, Carter Acquisition, Inc., a Delaware corporation ("Merger Sub") and a wholly-owned subsidiary of Carter Intermediate, Inc., a Delaware corporation ("Parent"), merged with and into Aegion Corporation (the "Company"), with the Company continuing as the surviving corporation (the "Merger"), pursuant to the previously announced Agreement and Plan of Merger, dated February 16, 2021 and amended on March 13, 2021 and April 13, 2021 (the "Merger Agreement") among Parent, Merger Sub and the Company. F2 · price: Pursuant to the Merger Agreement, at the effective time of the Merger: (a) each outstanding share of Common Stock (each, a "Share"), par value $0.01 per share, of the Company was cancelled and thereafter entitled the Reporting Person to receive $30 in cash without interest and less any applicable tax withholdings (the "Merger Consideration") and (b) each restricted stock unit and deferred stock unit (each a "Stock Unit") outstanding immediately prior to the consummation of the Merger became fully vested (to the extent unvested) and was canceled and converted into the right to receive, for each Share subject to such then-vested Stock Unit, the Merger Consideration. Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033151 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,162 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033151 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,266 Read SEC document |
| May 06, 2021 Filed May 10, 2021 16:58 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018951 · doc4.xml · derivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,256 Underlying: Common Stock · 5,764 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 14:32 UTC | Aegion Corp AEGN · Entity 139259 | GrantCommon Stock | 1,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-014473 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,110 F1 · security: Represents Deferred Stock Units ("DSUs") granted in lieu of the reporting person's 2020 second quarter cash retainer. Due to COVID-19, the issuer postponed the payment of the 2020 second quarter retainer to June 30, 2020, which would have been paid on April 1, 2020, and granted DSUs in lieu of cash. The DSUs equal the reporting person's second quarter retainer divided by the June 30, 2020 closing price of the issuer's common stock. Each DSU represents the issuer's obligation to transfer one share of the issuer's common stock, in accordance with the applicable DSU agreement. The DSUs were granted under the issuer's Non-Employee Director Equity Plan. Promptly following termination of the reporting person's service on the issuer's Board of Directors or at the reporting person's election of a specified distribution date, the issuer will distribute to the reporting person shares of the issuer's common stock equal to the number of DSUs granted. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029716 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,206 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029716 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,988 Read SEC document |
| May 07, 2020 Filed May 11, 2020 19:36 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 8,627 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012677 · doc4.xml · derivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,492 Underlying: Common Stock · 8,627 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of Deferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of Deferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| April 22, 2020 Filed Apr 23, 2020 19:17 UTC | Aegion Corp AEGN · Entity 139259 | GrantCommon Stock | 7,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-008363 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,676 F1 · shares: Annual award of deferred stock units ("DSUs"). Each DSU represents the issuer's obligation to transfer one share of the issuer's Class A common stock, $0.01 par value per share ("Common Stock"), in accordance with the terms of the deferred stock unit agreement pursuant to which the DSUs were granted. The DSUs were granted under the issuer's Non-Employee Director Equity Plan, and are subject to a one-year vesting period from the date of grant. Once the DSUs vest, shares of Common Stock equal to the number of DSUs reflected in the reporting person's account will be distributed to the reporting person either promptly following termination of the reporting person's service on the issuer's Board of Directors or, at the reporting person's election of a specified distribution date. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 18:10 UTC | Univar Solutions Inc. UNVR · Entity 110826 | PurchaseCommon Stock | 4,878 | $20.64 | $100,681.92 |
DisclosureSEC source: 0000899243-19-021386 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,894 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031374 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,197 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031374 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,450 Read SEC document |
| May 09, 2019 Filed May 10, 2019 16:33 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 5,624 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013052 · doc4.xml · derivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,865 Underlying: Common Stock · 5,624 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 16:41 UTC | Aegion Corp AEGN · Entity 139259 | GrantCommon Stock | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-007963 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,807 F1 · security: Historically, the reporting person has reported deferred stock unit ("DSU") grants as a separate line item. Going forward, the reporting person will combine both DSUs and Class A common stock, $0.01 par value per share ("Common Stock"), on one line, as has been done on this Form 4. F2 · shares: Annual award of DSUs. Each DSU represents the issuer's obligation to transfer one share of Common Stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSUs were granted. The DSUs were granted under the issuer's Non-Employee Director Equity Plan, and are subject to a one-year vesting period from the date of grant. Once the DSUs vest, shares of Common Stock equal to the number of DSUs reflected in the reporting person's account will be distributed to the reporting person either promptly following termination of the reporting person's service on the issuer's Board of Directors or, at the reporting person's election of a specified distribution date. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 22:53 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | PurchaseCommon Stock | 1,933 | $56.08 | $108,399.16 |
DisclosureSEC source: 0001209191-19-020107 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.95 to $56.19. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 23:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003324 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,732 Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 23:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003324 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,439 Read SEC document |
| May 09, 2018 Filed May 11, 2018 17:05 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 4,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009178 · doc4.xml · derivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,241 Underlying: Common Stock · 4,241 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 10:24 UTC | Aegion Corp AEGN · Entity 139259 | GrantDeferred Stock Units | 4,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-007913 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,907 F1 · security: Each deferred stock unit ("DSU") represents the issuer's obligation to transfer one share of Class A common stock, $0.01 par value per share ("Common Stock"), in accordance with the terms of the deferred stock unit agreement pursuant to which the DSUs were granted. The DSUs were granted under the issuer's Non-Employee Director Equity Plan, and are immediately vested upon grant. Shares of common stock equal to the number of DSUs reflected in the reporting person's account will be distributed to the reporting person either (i) promptly following termination of the undersigned's service on the issuer's Board of Directors, (ii) at the reporting person's election, or (iii) a specified distribution date. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 18:46 UTC | Aegion Corp AEGN · Entity 139259 | GrantCommon Stock | 5,800 | $22.04 | $127,820.98 |
DisclosureSEC source: 0001437749-18-003959 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,800 F1 · price: The price reported in Column 4 of this line item is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.69 to $22.15, inclusive. The reporting person undertakes to provide Aegion Corporation, any security holder of Aegion Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 19:05 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantCommon Stock | 3,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014939 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,016 F2 · shares: Restricted stock that vests in full on September 8, 2018, subject to the reporting person's continued board service through such date. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 19:05 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantCommon Stock | 3,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014939 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,653 F1 · shares: Retricted stock that vests in full on May 9, 2018, subject to the reporting person's continued board service through such date. Read SEC document |
| April 26, 2017 Filed Apr 27, 2017 16:17 UTC | Aegion Corp AEGN · Entity 139259 | GrantDeferred Stock Units | 4,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-007307 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 F1 · security: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of Class A common stock, $0.01 par value per share ("Common Stock"), in accordance with the terms of the deferred stock unit agreement pursuant to which the DSUs were granted. The DSUs were granted under the issuer's Non-Employee Director Equity Plan, and are immediately vested upon grant. Promptly following termination of the undersigned's service on the issuer's Board of Directors or, at the undersigned's election, a specified distribution date, the issuer will distribute to the undersigned shares of Common Stock equal to the number of DSUs reflected in the undersigned's account at such time. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:00 UTC | Aegion Corp AEGN · Entity 139259 | GrantDeferred Stock Unit | 1,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-000321 · rdgdoc.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 F1 · security: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of Class A common stock $.01 par value per share ("Common Stock"), in accordance with the terms of the deferred stock unit agreement pursuant to which the DSUs were granted. The DSUs were granted under the issuer's Non-Employee Director Equity Plan, and are immediately vested upon grant. Promptly following termination of the undersigned's service on the issuer's Board of Directors or, at the undersigned's election, a specified distribution date, the issuer will distribute to the undersigned shares of Common Stock equal to the number of DSUs reflected in the undersigned's account at such time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.